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Abstract

Ailanthus altissima Swingle (Simaroubaceae) is a medicinal plant used in traditional medicine as an
antiviral and an antitumoral drug. Its roots have been successively extracted, at room temperature, with
solvents of increasing polarity. The extracts were tested for their antiproliferative activity on HeLa
(human cervical carcinoma cell line), at a dose of 10 µg/mL. The chloroform extract, the most active in
biological assays, was fractionated on a silica-gel column: the fractions obtained were assayed on the
proliferation of the same cellular line, at a dose of 10 mg/mL. The most active fraction (100% of cytotoxic
activity) demonstrated to contain a single substance. The identification of this active substance,
recognized as 1-methoxy-canthin-6-one, was performed by NMR methods. This indole alkaloid has shown
antiproliferative and proapoptotic effects on several tumoral cell lines. In particular, it provoked
mitochondrial membrane depolarization, mitochondrial release of cytochrome c and Smac/DIABLO, and
caspase 3 activation on Jurkat cells (human leukemia cell line). The compound was active also on other
tumor cell lines, HuH7 (hepatocellular carcinoma), NPA (human papillary carcinoma), and ARO
(anaplastic thyroid cell line): the apoptosis-inducing activity was evident at a concentration of
< 10 µmol/L until half maximal at about 40 µmol/L. Peripheral blood mononuclear cells (PBMC) from
healthy subjects have been used as control; in these cells, the alkaloid showed no proapoptotic activity.
The effects of 1-methoxy-canthin-6-one, in combination with TRAIL (human recombinant tumor necrosis
factor-related apoptosis-inducing ligand), has also been investigated on Jurkat cells using suboptimal
concentrations of both agents, showing 45% apoptosis. Also, the TMRE (tetramethylrhodamine ethyl
ester) bioassay resulted in a definite mitochondrial membrane depolarization, when alkaloid and TRAIL
are used together, always using their suboptimal concentrations. The study of the possible synergism has
shown that the alkaloid increases TRAIL R1 receptors, inducing JNK activation and c-Jun
phosphorylation. JNK inhibition reduces only partly the synergism between alkaloid and TRAIL;
therefore, other factors take part in TRAIL-induced apoptosis, besides TRAIL R1 upregulation. In order to
obtain more information about biological properties of 1-methoxy-canthin-6-one and to investigate on
chemical requirements responsible for its biological activity, a series of novel 1,4-disubstituted and 1,4,9trisubstituted β-carbolines and tetracyclic derivatives were designed and synthesized. In vitro cytotoxic
activities of these compounds were studied in a human tumor cell line panel. Almost all compounds
demonstrated antiproliferative effects, in particular against prostate cancer cells PC-3, with an IC50 values
ranging between 60 and 8 µM. The most active derivatives were tested to evaluate the possible interaction
with DNA and inhibition of topoisomerase I. None of these compounds were observed to stabilize the
DNA–Topo I complex, thereby poisoning the reaction. In particular, 3-benzyl-1-methoxy-canthin-6onium bromide exhibited strong inhibition of Topo I, with IC50 of 17.77 µM.

